Diet-induced obesity causes visceral, but not subcutaneous, lymph node hyperplasia via increases in specific immune cell populations
- PMID: 28762561
- PMCID: PMC5585052
- DOI: 10.1111/cpr.12365
Diet-induced obesity causes visceral, but not subcutaneous, lymph node hyperplasia via increases in specific immune cell populations
Abstract
Objectives: The spatial proximity of adipose depots to secondary lymph nodes allows a unique relation between the two systems. Obesity, predominately visceral adiposity, links to numerous diseases; hence, we postulate that secondary lymphatics within this region contributes to disease risk.
Material and methods: Male C57BL/6 mice were fed standard CHOW (18% kcal fat) or Western diet (45% kcal fat) for 7 weeks. Visceral and subcutaneous lymph nodes and associated adipose depots they occupy were excised. Lymph node morphology and resident immune cell populations were characterized via histopathology, immunofluorescence and flow cytometry. Adipose tissue immune cell populations were also characterized.
Results: Obesity caused lymph node expansion, increased viable cell number and deviations in immune cell populations. These alterations were exclusive to visceral lymph nodes. Notably, pro-inflammatory antigen presenting cells and regulatory T cells increased in number in the visceral lymph node. Obesity, however, reduced T regulatory cells in visceral lymph nodes. The visceral adipose depot also had greater reactivity towards HFD than subcutaneous, with a greater percent of macrophages, dendritic and CD8+ T cells. Immune cell number, in both the visceral and subcutaneous, however decreased as adipose depots enlarged.
Conclusion: Overall, HFD has a greater influence on visceral cavity than the subcutaneous. In the visceral lymph node, but not subcutaneous, HFD-induced obesity decreased cell populations that suppressed immune function while increasing those that regulate/activate immune response.
© 2017 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6529140/bin/CPR-50-na-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6529140/bin/CPR-50-na-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6529140/bin/CPR-50-na-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6529140/bin/CPR-50-na-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6529140/bin/CPR-50-na-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6529140/bin/CPR-50-na-g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6529140/bin/CPR-50-na-g007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6529140/bin/CPR-50-na-g008.gif)
Similar articles
-
High-fat diet induced central adiposity (visceral fat) is associated with increased fibrosis and decreased immune cellularity of the mesenteric lymph node in mice.Eur J Nutr. 2020 Jun;59(4):1641-1654. doi: 10.1007/s00394-019-02019-z. Epub 2019 Jun 4. Eur J Nutr. 2020. PMID: 31165249 Free PMC article.
-
Obesity-induced immune dysfunction and immunosuppression: TEM observation of visceral and subcutaneous lymph node microarchitecture and immune cell interactions.Horm Mol Biol Clin Investig. 2019 May 28;39(2):/j/hmbci.2019.39.issue-2/hmbci-2018-0083/hmbci-2018-0083.xml. doi: 10.1515/hmbci-2018-0083. Horm Mol Biol Clin Investig. 2019. PMID: 31136298
-
Adipose tissue extrinsic factor: Obesity-induced inflammation and the role of the visceral lymph node.Physiol Behav. 2018 Jun 1;190:71-81. doi: 10.1016/j.physbeh.2018.02.044. Epub 2018 Mar 1. Physiol Behav. 2018. PMID: 29501838 Free PMC article.
-
Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice.Lipids Health Dis. 2012 Feb 7;11:21. doi: 10.1186/1476-511X-11-21. Lipids Health Dis. 2012. PMID: 22313574 Free PMC article.
-
Obesity associated disease risk: the role of inherent differences and location of adipose depots.Horm Mol Biol Clin Investig. 2018 Mar 16;33(2):/j/hmbci.2018.33.issue-2/hmbci-2018-0012/hmbci-2018-0012.xml. doi: 10.1515/hmbci-2018-0012. Horm Mol Biol Clin Investig. 2018. PMID: 29547393 Review.
Cited by
-
Dietary glucosinolates inhibit splenic inflammation in high fat/cholesterol diet-fed C57BL/6 mice.Nutr Res Pract. 2021 Dec;15(6):798-806. doi: 10.4162/nrp.2021.15.6.798. Epub 2021 May 18. Nutr Res Pract. 2021. PMID: 34858556 Free PMC article.
-
Adipose Tissue and Biological Factors. Possible Link between Lymphatic System Dysfunction and Obesity.Metabolites. 2021 Sep 11;11(9):617. doi: 10.3390/metabo11090617. Metabolites. 2021. PMID: 34564433 Free PMC article. Review.
-
Innate Immune System Orchestrates Metabolic Homeostasis and Dysfunction in Visceral Adipose Tissue During Obesity.Front Immunol. 2021 Aug 6;12:702835. doi: 10.3389/fimmu.2021.702835. eCollection 2021. Front Immunol. 2021. PMID: 34421909 Free PMC article. Review.
-
Visceral Obesity Promotes Lung Cancer Progression-Toward Resolution of the Obesity Paradox in Lung Cancer.J Thorac Oncol. 2021 Aug;16(8):1333-1348. doi: 10.1016/j.jtho.2021.04.020. Epub 2021 May 25. J Thorac Oncol. 2021. PMID: 34144926 Free PMC article.
-
Effects of Obesity on Axillary Lymph Node Structure: Association of Hilar Fat Deposition and Alterations in Cortex Width.Maedica (Bucur). 2020 Mar;15(1):99-104. doi: 10.26574/maedica.2020.15.1.99. Maedica (Bucur). 2020. PMID: 32419869 Free PMC article.
References
-
- Health, United States, 2014: With Special Feature on Adults 55‐64. Centers for Disease Control and Prevention; 2014.
-
- Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13:981‐1000. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials